Sirolimus is a potent immunosuppressive antiproliferative drug that acts to reduce Il-2–induced proliferation of lymphocytes by binding to FK binding protein and.
Most of the immunosuppressants are powerful drugs, and hence have side Calcineurin Inhibitors: Tacrolimus and Cyclosporine; Antiproliferative agents.
Interv Cardiol Clin. Jul;5(3) doi: /dads-space.com Epub Jun Antiproliferative Drugs for Restenosis Prevention. Habib A(1).
Curr Med Chem Cardiovasc Hematol Agents. Jul;3(3) Stent-based delivered anti-proliferative drugs in the prevention of coronary stent restenosis.
Particularly, the newer antiproliferative immunosuppressive drugs (agents that directly inhibit the proliferation of T and B lymphocytes) have had an important.
Antiproliferative drug-coated stents are a possible solution for post-angioplasty coronary restenosis. Here we analyze their efficacy, effectiveness and safety, and .
British J7ournal of Ophthalmology ; Antiproliferative agents and the prevention ofscarring after surgery: friend or foe? The use of antiproliferative.
After the addition of a drug, if the number of cells in the plate are between and then this refers to growth inhibition which is a measure of antiproliferative.
Sigma-Aldrich Online Catalog Product List: Anti-Proliferative Agents.